Religious Freedom Over Mandates Act This bill prohibits the use of federal funds for a record system that captures religious accommodations (e.g., exemptions) related to COVID-19 vaccination requirements requested by or granted to an employee, contractor, volunteer, or any other person.
Rep. Jeff Duncan
Sponsored bills
Protecting Life in Health Savings Accounts Act This bill prohibits distributions from health savings accounts (HSAs) or other tax-preferred savings accounts for abortions except for abortions to terminate a pregnancy that is the result or rape or incest or to protect a women's health or life.
Maddy summaryThis resolution expresses the U.S. House of Representatives' support for designating January 23-29, 2022, as "National School Choice Week." It encourages parents to learn about K-12 education options (including public, charter, private, and online schools) and promotes public awareness of educational choice benefits during that week. The resolution does not create new laws or policies but serves as a symbolic gesture to highlight parental choice in education. It was introduced by multiple representatives and referred to the Education and Labor Committee.
Financial Accountability for Uniquely Compensated Individuals Act or the FAUCI Act This bill broadens the scope of executive branch employees and officers whose financial disclosures are subject to automatic electronic publication by including highly compensated executive branch officers and employees. The bill also requires the Office of Government Ethics to provide public access to a list of highly compensated executive branch officers and employees who file confidential financial disclosures under existing law, including the specific types of information disclosed in the confidential report.
No Mandates for Healthcare Workers Act This bill prohibits the Centers for Medicare & Medicaid Services (CMS) from requiring any drug or vaccine or other biological product to be administered to employees of health care providers as a condition of Medicare and Medicaid participation. On November 5, 2021, the CMS issued a rule titled Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination . The rule requires health care providers, as a condition of Medicare and Medicaid participation, to ensure that staff are fully vaccinated against COVID-19.
No Mandates Act This bill prohibits federal agencies and certain entities that receive federal funding from requiring COVID-19 vaccinations. Specifically, federal agencies may not issue rules, regulations, or guidance that require an individual to receive a COVID-19 vaccination. The bill also prohibits requiring a COVID-19 vaccination to access federal property and services or congressional grounds and services. Additionally, an entity that received federal COVID-19 relief funds or receives other federal funds after this bill's enactment may not require a COVID-19 vaccination as a condition of providing any service to an individual.
This bill nullifies Order 2021-148 of the Mayor of the District of Columbia (December 22, 2021) and any successor or substantially similar order of the Mayor of the District of Columbia that imposes a COVID-19 vaccine requirement for entry to certain establishments and facilities in the District.
Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials. The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.
Protecting International Pipelines for Energy Security Act This bill requires the President to obtain the approval of Congress before revoking a permit or other authorization required under executive orders for constructing, connecting, operating, or maintaining an oil or natural gas pipeline, an electric transmission facility, or a border-crossing facility.
Protecting Our Democracy by Preventing Foreign Citizens from Voting Act This bill prohibits federal funds from being made available to state or local governments that allow noncitizens to vote in federal, state, or local elections.